2006
DOI: 10.1186/1471-2407-6-41
|View full text |Cite
|
Sign up to set email alerts
|

Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein

Abstract: Background: CEA is a tumor-associated antigen abundantly expressed on several cancer types, including those naturally refractory to chemotherapy. The selection and characterization of human anti-CEA single-chain antibody fragments (scFv) is a first step toward the construction of new anticancer monoclonal antibodies designed for optimal blood clearance and tumor penetration.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(23 citation statements)
references
References 33 publications
0
23
0
Order By: Relevance
“…The reasoning behind our scFv format was to preserve the genetic source of the antibody fragment by cloning it into a phagemid vector and utilizing relatively simple production in bacteria. Furthermore, the small molecular size of scFv should provide high tissue penetration efficiency (Kioi et al, 2008;Liu et al, 2008;Stirnemann et al, 2008), and a lack of significant toxicity (Korn et al, 2004;Yang et al, 2007a;Nam et al, 2008) while giving rapid plasma clearance (Mao et al, 1999;Hamilton et al, 2002;Olafsen et al, 2004;Pavoni et al, 2006), which makes such an antibody a potentially suitable candidate for clinical application.…”
Section: Discussionmentioning
confidence: 99%
“…The reasoning behind our scFv format was to preserve the genetic source of the antibody fragment by cloning it into a phagemid vector and utilizing relatively simple production in bacteria. Furthermore, the small molecular size of scFv should provide high tissue penetration efficiency (Kioi et al, 2008;Liu et al, 2008;Stirnemann et al, 2008), and a lack of significant toxicity (Korn et al, 2004;Yang et al, 2007a;Nam et al, 2008) while giving rapid plasma clearance (Mao et al, 1999;Hamilton et al, 2002;Olafsen et al, 2004;Pavoni et al, 2006), which makes such an antibody a potentially suitable candidate for clinical application.…”
Section: Discussionmentioning
confidence: 99%
“…29,34 The small size offers a convenient affinity maturation principle. Unlike complex multistep affinity maturations of antibodies, 21,35 here, a single oligonucleotide could be used to generate the affinity maturation library in one step, in a similar fashion as a previously described affinity maturation of a HER2-binding Affibody molecule. 36 Furthermore, Affibody molecules can easily be site-specifically labeled, either via a cysteine residue introduced upon recombinant expression or through the incorporation of suitable chelators upon peptide synthesis.…”
Section: Introductionmentioning
confidence: 98%
“…Among various antibody forms, the antigen-binding fragment or singlechain variable fragment (scFv) displayed on the phage is highly suitable and fast for selecting specific antibodies (23)(24)(25). Among the many animals that are adequate as animal models for producing antibodies against immunizing antigens, chickens are the most convenient and rapid host for constructing antibody libraries for selecting specific scFvs against various targets for therapy or diagnosis (24,26,27).…”
mentioning
confidence: 99%